Jane Wasman Insider Trading $ACOR ACORDA THERAPEUTICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jane Wasman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jane Wasman. Jane Wasman is Chief, St. Dev. and Gen. Coun in ACORDA THERAPEUTICS INC ($ACOR) and Exec VP, General Counsel & Sec in ACORDA THERAPEUTICS INC ($ACOR).
Jane Wasman in ACORDA THERAPEUTICS INC
Trading Symbol: ACORIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jane Wasman: Chief, St. Dev. and Gen. Coun, Exec VP, General Counsel & Sec
Holdings: 74,970 shares
Current Value: $1,589,364
Latest Transaction: Mar 19 2012
$ACOR Market Capitalization: $941.09M
$ACOR Previous Close: $21.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jane Wasman in ACORDA THERAPEUTICS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Chief, St. Dev. and ... | Option Exercise | A | 26.35 | 52,200 | 1,375,470 | 52,200 | |
Mar 19 2012 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Chief, St. Dev. and ... | Grant | A | 0.00 | 17,400 | 0 | 74,970 | 57.6 K to 75 K (+30.22 %) |
Dec 05 2011 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.92 | 7,344 | 168,324 | 57,570 | 64.9 K to 57.6 K (-11.31 %) |
Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Option Exercise | A | 22.06 | 56,250 | 1,240,875 | 56,250 | |
Mar 07 2011 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Grant | A | 0.00 | 18,750 | 0 | 64,914 | 46.2 K to 64.9 K (+40.62 %) |
Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 26.38 | 4,900 | 129,262 | 46,164 | 51.1 K to 46.2 K (-9.60 %) |
Dec 03 2010 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 26.82 | 2,600 | 69,732 | 51,064 | 53.7 K to 51.1 K (-4.84 %) |
Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Option Exercise | A | 34.20 | 40,000 | 1,368,000 | 40,000 | |
Apr 02 2010 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Grant | A | 0.00 | 20,000 | 0 | 53,664 | 33.7 K to 53.7 K (+59.41 %) |
Dec 02 2009 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.50 | 5,000 | 122,507 | 33,664 | 38.7 K to 33.7 K (-12.93 %) |
Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Option Exercise | A | 20.59 | 37,500 | 772,125 | 37,500 | |
Mar 04 2009 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Grant | A | 0.00 | 15,000 | 0 | 38,664 | 23.7 K to 38.7 K (+63.39 %) |
Dec 03 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.98 | 2,500 | 39,950 | 23,664 | 26.2 K to 23.7 K (-9.56 %) |
Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Option Exercise | M | 5.85 | 3,500 | 20,475 | 25,000 | |
Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.71 | 100 | 3,171 | 26,164 | 26.3 K to 26.2 K (-0.38 %) |
Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.66 | 100 | 3,166 | 26,264 | 26.4 K to 26.3 K (-0.38 %) |
Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.65 | 100 | 3,165 | 26,364 | 26.5 K to 26.4 K (-0.38 %) |
Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.64 | 200 | 6,328 | 26,464 | 26.7 K to 26.5 K (-0.75 %) |
Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.59 | 200 | 6,318 | 26,664 | 26.9 K to 26.7 K (-0.74 %) |
Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.58 | 100 | 3,158 | 26,864 | 27 K to 26.9 K (-0.37 %) |
Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.57 | 400 | 12,628 | 26,964 | 27.4 K to 27 K (-1.46 %) |
Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.56 | 600 | 18,936 | 27,364 | 28 K to 27.4 K (-2.15 %) |
Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 31.50 | 1,700 | 53,550 | 27,964 | 29.7 K to 28 K (-5.73 %) |
Jun 13 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Buy | M | 5.85 | 3,500 | 20,475 | 29,664 | 26.2 K to 29.7 K (+13.38 %) |
May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.00 | 500 | 9,500 | 26,164 | 26.7 K to 26.2 K (-1.88 %) |
May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.05 | 800 | 15,240 | 26,664 | 27.5 K to 26.7 K (-2.91 %) |
May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.10 | 400 | 7,640 | 27,464 | 27.9 K to 27.5 K (-1.44 %) |
May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.15 | 300 | 5,745 | 27,864 | 28.2 K to 27.9 K (-1.07 %) |
May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.20 | 200 | 3,840 | 28,164 | 28.4 K to 28.2 K (-0.71 %) |
May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.45 | 225 | 4,376 | 28,364 | 28.6 K to 28.4 K (-0.79 %) |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Option Exercise | A | 19.81 | 37,500 | 742,875 | 37,500 | |
Mar 07 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Grant | A | 0.00 | 15,000 | 0 | 28,589 | 13.6 K to 28.6 K (+110.38 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.90 | 410 | 9,389 | 13,589 | 14 K to 13.6 K (-2.93 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.91 | 15 | 344 | 13,999 | 14 K to 14 K (-0.11 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.00 | 1,283 | 29,509 | 14,014 | 15.3 K to 14 K (-8.39 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.03 | 17 | 392 | 15,297 | 15.3 K to 15.3 K (-0.11 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.04 | 500 | 11,520 | 15,314 | 15.8 K to 15.3 K (-3.16 %) |
Feb 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.07 | 200 | 4,614 | 15,814 | 16 K to 15.8 K (-1.25 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.30 | 325 | 7,248 | 16,014 | 16.3 K to 16 K (-1.99 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.31 | 175 | 3,904 | 16,339 | 16.5 K to 16.3 K (-1.06 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.35 | 225 | 5,029 | 16,514 | 16.7 K to 16.5 K (-1.34 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.36 | 200 | 4,472 | 16,739 | 16.9 K to 16.7 K (-1.18 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.37 | 400 | 8,948 | 16,939 | 17.3 K to 16.9 K (-2.31 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 22.46 | 300 | 6,738 | 17,339 | 17.6 K to 17.3 K (-1.70 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.50 | 400 | 9,400 | 17,639 | 18 K to 17.6 K (-2.22 %) |
Jan 24 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 23.64 | 400 | 9,456 | 18,039 | 18.4 K to 18 K (-2.17 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.50 | 1,112 | 22,796 | 18,439 | 19.6 K to 18.4 K (-5.69 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.51 | 88 | 1,805 | 19,551 | 19.6 K to 19.6 K (-0.45 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.60 | 400 | 8,240 | 19,639 | 20 K to 19.6 K (-2.00 %) |
Dec 21 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.62 | 825 | 17,012 | 20,039 | 20.9 K to 20 K (-3.95 %) |
Nov 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.57 | 500 | 9,285 | 20,864 | 21.4 K to 20.9 K (-2.34 %) |
Nov 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.63 | 500 | 9,315 | 21,364 | 21.9 K to 21.4 K (-2.29 %) |
Nov 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.85 | 825 | 15,551 | 21,864 | 22.7 K to 21.9 K (-3.64 %) |
Nov 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.00 | 600 | 11,400 | 22,689 | 23.3 K to 22.7 K (-2.58 %) |
Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.95 | 240 | 4,788 | 23,289 | 23.5 K to 23.3 K (-1.02 %) |
Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.00 | 480 | 9,600 | 23,529 | 24 K to 23.5 K (-2.00 %) |
Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.05 | 265 | 5,313 | 24,009 | 24.3 K to 24 K (-1.09 %) |
Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.10 | 240 | 4,824 | 24,274 | 24.5 K to 24.3 K (-0.98 %) |
Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.15 | 240 | 4,836 | 24,514 | 24.8 K to 24.5 K (-0.97 %) |
Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.20 | 240 | 4,848 | 24,754 | 25 K to 24.8 K (-0.96 %) |
Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.25 | 480 | 9,720 | 24,994 | 25.5 K to 25 K (-1.88 %) |
Oct 25 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 20.35 | 240 | 4,884 | 25,474 | 25.7 K to 25.5 K (-0.93 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.56 | 200 | 3,712 | 25,714 | 25.9 K to 25.7 K (-0.77 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.60 | 200 | 3,720 | 25,914 | 26.1 K to 25.9 K (-0.77 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.64 | 200 | 3,728 | 26,114 | 26.3 K to 26.1 K (-0.76 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.70 | 200 | 3,740 | 26,314 | 26.5 K to 26.3 K (-0.75 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.75 | 250 | 4,688 | 26,514 | 26.8 K to 26.5 K (-0.93 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.81 | 375 | 7,054 | 26,764 | 27.1 K to 26.8 K (-1.38 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.82 | 100 | 1,882 | 27,139 | 27.2 K to 27.1 K (-0.37 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.83 | 100 | 1,883 | 27,239 | 27.3 K to 27.2 K (-0.37 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.85 | 100 | 1,885 | 27,339 | 27.4 K to 27.3 K (-0.36 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 18.86 | 150 | 2,829 | 27,439 | 27.6 K to 27.4 K (-0.54 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.00 | 300 | 5,700 | 27,589 | 27.9 K to 27.6 K (-1.08 %) |
Sep 27 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.05 | 250 | 4,763 | 27,889 | 28.1 K to 27.9 K (-0.89 %) |
Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.68 | 200 | 3,336 | 28,139 | 28.3 K to 28.1 K (-0.71 %) |
Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.70 | 200 | 3,340 | 28,339 | 28.5 K to 28.3 K (-0.70 %) |
Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.73 | 200 | 3,346 | 28,539 | 28.7 K to 28.5 K (-0.70 %) |
Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.83 | 200 | 3,366 | 28,739 | 28.9 K to 28.7 K (-0.69 %) |
Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 16.98 | 200 | 3,396 | 28,939 | 29.1 K to 28.9 K (-0.69 %) |
Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 17.04 | 200 | 3,408 | 29,139 | 29.3 K to 29.1 K (-0.68 %) |
Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 17.06 | 200 | 3,412 | 29,339 | 29.5 K to 29.3 K (-0.68 %) |
Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 17.09 | 200 | 3,418 | 29,539 | 29.7 K to 29.5 K (-0.67 %) |
Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 17.23 | 625 | 10,769 | 29,739 | 30.4 K to 29.7 K (-2.06 %) |
Aug 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 17.58 | 200 | 3,516 | 30,364 | 30.6 K to 30.4 K (-0.65 %) |
May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.13 | 300 | 7,239 | 30,564 | 30.9 K to 30.6 K (-0.97 %) |
May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.32 | 200 | 4,864 | 30,864 | 31.1 K to 30.9 K (-0.64 %) |
May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.61 | 300 | 7,383 | 31,064 | 31.4 K to 31.1 K (-0.96 %) |
May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.63 | 300 | 7,389 | 31,364 | 31.7 K to 31.4 K (-0.95 %) |
May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 24.96 | 300 | 7,488 | 31,664 | 32 K to 31.7 K (-0.94 %) |
May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 25.00 | 300 | 7,500 | 31,964 | 32.3 K to 32 K (-0.93 %) |
May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 25.04 | 300 | 7,512 | 32,264 | 32.6 K to 32.3 K (-0.92 %) |
May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 25.06 | 300 | 7,518 | 32,564 | 32.9 K to 32.6 K (-0.91 %) |
May 11 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 25.07 | 300 | 7,521 | 32,864 | 33.2 K to 32.9 K (-0.90 %) |
Feb 16 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Option Exercise | A | 22.13 | 63,183 | 1,398,240 | 148,144 | |
Feb 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 21.07 | 300 | 6,321 | 33,164 | 33.5 K to 33.2 K (-0.90 %) |
Feb 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 21.15 | 300 | 6,345 | 33,464 | 33.8 K to 33.5 K (-0.89 %) |
Feb 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 21.29 | 300 | 6,387 | 33,764 | 34.1 K to 33.8 K (-0.88 %) |
Feb 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 21.34 | 300 | 6,402 | 34,064 | 34.4 K to 34.1 K (-0.87 %) |
Feb 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 21.38 | 300 | 6,414 | 34,364 | 34.7 K to 34.4 K (-0.87 %) |
Feb 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 21.45 | 300 | 6,435 | 34,664 | 35 K to 34.7 K (-0.86 %) |
Feb 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 21.50 | 300 | 6,450 | 34,964 | 35.3 K to 35 K (-0.85 %) |
Feb 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 21.98 | 300 | 6,594 | 35,264 | 35.6 K to 35.3 K (-0.84 %) |
Feb 13 2007 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 21.99 | 200 | 4,398 | 35,564 | 35.8 K to 35.6 K (-0.56 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.13 | 2,051 | 31,032 | 35,764 | 37.8 K to 35.8 K (-5.42 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.14 | 100 | 1,514 | 37,815 | 37.9 K to 37.8 K (-0.26 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.15 | 200 | 3,030 | 37,915 | 38.1 K to 37.9 K (-0.52 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.16 | 300 | 4,548 | 38,115 | 38.4 K to 38.1 K (-0.78 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.17 | 200 | 3,034 | 38,415 | 38.6 K to 38.4 K (-0.52 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.18 | 400 | 6,072 | 38,615 | 39 K to 38.6 K (-1.03 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.19 | 200 | 3,038 | 39,015 | 39.2 K to 39 K (-0.51 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.20 | 400 | 6,080 | 39,215 | 39.6 K to 39.2 K (-1.01 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.21 | 300 | 4,563 | 39,615 | 39.9 K to 39.6 K (-0.75 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.22 | 200 | 3,044 | 39,915 | 40.1 K to 39.9 K (-0.50 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.23 | 100 | 1,523 | 40,115 | 40.2 K to 40.1 K (-0.25 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.32 | 300 | 4,596 | 40,215 | 40.5 K to 40.2 K (-0.74 %) |
Nov 13 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.38 | 100 | 1,538 | 40,515 | 40.6 K to 40.5 K (-0.25 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.89 | 100 | 1,489 | 40,615 | 40.7 K to 40.6 K (-0.25 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.91 | 100 | 1,491 | 40,715 | 40.8 K to 40.7 K (-0.25 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.92 | 100 | 1,492 | 40,815 | 40.9 K to 40.8 K (-0.24 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.93 | 200 | 2,986 | 40,915 | 41.1 K to 40.9 K (-0.49 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.94 | 300 | 4,482 | 41,115 | 41.4 K to 41.1 K (-0.72 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.95 | 100 | 1,495 | 41,415 | 41.5 K to 41.4 K (-0.24 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.96 | 221 | 3,306 | 41,515 | 41.7 K to 41.5 K (-0.53 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 14.99 | 100 | 1,499 | 41,736 | 41.8 K to 41.7 K (-0.24 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.00 | 479 | 7,185 | 41,836 | 42.3 K to 41.8 K (-1.13 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.02 | 200 | 3,004 | 42,315 | 42.5 K to 42.3 K (-0.47 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.05 | 100 | 1,505 | 42,515 | 42.6 K to 42.5 K (-0.23 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.10 | 100 | 1,510 | 42,615 | 42.7 K to 42.6 K (-0.23 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.13 | 500 | 7,565 | 42,715 | 43.2 K to 42.7 K (-1.16 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.24 | 200 | 3,048 | 43,215 | 43.4 K to 43.2 K (-0.46 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.25 | 100 | 1,525 | 43,415 | 43.5 K to 43.4 K (-0.23 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.28 | 200 | 3,056 | 43,515 | 43.7 K to 43.5 K (-0.46 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.29 | 400 | 6,116 | 43,715 | 44.1 K to 43.7 K (-0.91 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.30 | 100 | 1,530 | 44,115 | 44.2 K to 44.1 K (-0.23 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.32 | 100 | 1,532 | 44,215 | 44.3 K to 44.2 K (-0.23 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.33 | 300 | 4,599 | 44,315 | 44.6 K to 44.3 K (-0.67 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.38 | 100 | 1,538 | 44,615 | 44.7 K to 44.6 K (-0.22 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.39 | 200 | 3,078 | 44,715 | 44.9 K to 44.7 K (-0.45 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.41 | 100 | 1,541 | 44,915 | 45 K to 44.9 K (-0.22 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.42 | 100 | 1,542 | 45,015 | 45.1 K to 45 K (-0.22 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.43 | 100 | 1,543 | 45,115 | 45.2 K to 45.1 K (-0.22 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.45 | 100 | 1,545 | 45,215 | 45.3 K to 45.2 K (-0.22 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.45 | 416 | 6,427 | 45,315 | 45.7 K to 45.3 K (-0.91 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.46 | 500 | 7,730 | 45,731 | 46.2 K to 45.7 K (-1.08 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.47 | 484 | 7,487 | 46,231 | 46.7 K to 46.2 K (-1.04 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.48 | 400 | 6,192 | 46,715 | 47.1 K to 46.7 K (-0.85 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.49 | 300 | 4,647 | 47,115 | 47.4 K to 47.1 K (-0.63 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.50 | 700 | 10,850 | 47,415 | 48.1 K to 47.4 K (-1.45 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.56 | 100 | 1,556 | 48,115 | 48.2 K to 48.1 K (-0.21 %) |
Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 15.57 | 100 | 1,557 | 48,215 | 48.3 K to 48.2 K (-0.21 %) |